Moritz Stuplich

1.3k total citations
15 papers, 368 citations indexed

About

Moritz Stuplich is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Moritz Stuplich has authored 15 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Moritz Stuplich's work include Glioma Diagnosis and Treatment (12 papers), Brain Metastases and Treatment (7 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Moritz Stuplich is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), Brain Metastases and Treatment (7 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Moritz Stuplich collaborates with scholars based in Germany, Switzerland and United States. Moritz Stuplich's co-authors include Martin Glas, Ulrich Herrlinger, Matthias Simon, Niklas Schäfer, Frederic Mack, Christina Schaub, Sied Kebir, Björn Scheffler, Karl‐Josef Langen and Andreas F. Hottinger and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Acta Neuropathologica.

In The Last Decade

Moritz Stuplich

15 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Moritz Stuplich Germany	11	275	122	121	68	54	15	368
Despina Misailidou Greece	8	278 1.0×	183 1.5×	98 0.8×	92 1.4×	75 1.4×	9	417
Frederic Mack Germany	10	267 1.0×	166 1.4×	121 1.0×	51 0.8×	56 1.0×	12	374
Heinrich Elinzano United States	10	273 1.0×	104 0.9×	123 1.0×	73 1.1×	54 1.0×	18	380
J. Curschmann Switzerland	4	331 1.2×	172 1.4×	98 0.8×	67 1.0×	65 1.2×	6	431
Ryo Nosaka Japan	11	179 0.7×	83 0.7×	88 0.7×	64 0.9×	33 0.6×	24	343
Sophie E. M. Veldhuijzen van Zanten Netherlands	14	231 0.8×	97 0.8×	151 1.2×	98 1.4×	51 0.9×	37	445
Praveen Medabalmi United States	6	245 0.9×	76 0.6×	64 0.5×	113 1.7×	106 2.0×	10	394
T. Gorlia Belgium	8	281 1.0×	161 1.3×	41 0.3×	93 1.4×	71 1.3×	15	367
Jean-Yves Delattre France	10	240 0.9×	177 1.5×	52 0.4×	49 0.7×	33 0.6×	11	306
Ralf Ketter Germany	12	286 1.0×	130 1.1×	105 0.9×	97 1.4×	87 1.6×	25	515

Countries citing papers authored by Moritz Stuplich

Since Specialization

Citations

This map shows the geographic impact of Moritz Stuplich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moritz Stuplich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moritz Stuplich more than expected).

Fields of papers citing papers by Moritz Stuplich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moritz Stuplich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moritz Stuplich. The network helps show where Moritz Stuplich may publish in the future.

Co-authorship network of co-authors of Moritz Stuplich

This figure shows the co-authorship network connecting the top 25 collaborators of Moritz Stuplich. A scholar is included among the top collaborators of Moritz Stuplich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moritz Stuplich. Moritz Stuplich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Schaub, Christina, Niklas Schäfer, Frederic Mack, et al.. (2016). The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastoma. Journal of Cancer Research and Clinical Oncology. 142(8). 1825–1829. 13 indexed citations

Kebir, Sied, Florian Gaertner, Marcus Mueller, et al.. (2016). 18F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report. Oncology Letters. 11(3). 2195–2198. 13 indexed citations

Herrlinger, Ulrich, David Jones, Martin Glas, et al.. (2015). Gliomatosis cerebri: no evidence for a separate brain tumor entity. Acta Neuropathologica. 131(2). 309–319. 58 indexed citations

Kebir, Sied, Rolf Fimmers, Norbert Galldiks, et al.. (2015). Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET. Clinical Cancer Research. 22(9). 2190–2196. 93 indexed citations

Mack, Frederic, Niklas Schäfer, Sied Kebir, et al.. (2014). Carmustine (BCNU) plus Teniposide (VM26) in Recurrent Malignant Glioma. Oncology. 86(5-6). 369–372. 14 indexed citations

Schaub, Christina, Susanne Greschus, Andreas Waha, et al.. (2013). FLAIR-Only Progression in Bevacizumab-Treated Relapsing Glioblastoma Does Not Predict Short Survival. Oncology. 85(3). 191–195. 13 indexed citations

Schäfer, Niklas, Björn Scheffler, Moritz Stuplich, et al.. (2013). Vemurafenib for Leptomeningeal Melanomatosis. Journal of Clinical Oncology. 31(11). e173–e174. 40 indexed citations

Kebir, Sied, K. Kuchelmeister, Pitt Niehusmann, et al.. (2012). Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy. Experimental Hematology and Oncology. 1(1). 37–37. 8 indexed citations

Stuplich, Moritz, Dariusch R. Hadizadeh, K. Kuchelmeister, et al.. (2012). Late and Prolonged Pseudoprogression in Glioblastoma After Treatment With Lomustine and Temozolomide. Journal of Clinical Oncology. 30(21). e180–e183. 40 indexed citations

10.

Schäfer, Niklas, Julia Tichy, Sharmilan Thanendrarajan, et al.. (2011). Ifosfamide, Carboplatin and Etoposide in Recurrent Malignant Glioma. Oncology. 80(5-6). 330–332. 16 indexed citations

11.

Stuplich, Moritz, Karin Mayer, Young Kim, et al.. (2011). Richter Syndrome and Brain Involvement: Low-Grade Lymphoma Relapsing as Cerebral High-Grade Lymphoma. Acta Haematologica. 127(2). 93–95. 6 indexed citations

12.

Stuplich, Moritz, et al.. (2011). Relapse of primary central nervous system lymphoma 13 years after high-dose methotrexate-based polychemotherapy. Journal of Clinical Neuroscience. 18(11). 1554–1555. 1 indexed citations

13.

Glas, Martin, Thomas Hundsberger, Moritz Stuplich, et al.. (2009). Nimustine (ACNU) Plus Teniposide (VM26) in Recurrent Glioblastoma. Oncology. 76(3). 184–189. 17 indexed citations

14.

Glas, Martin, Thomas Hundsberger, Moritz Stuplich, et al.. (2008). Nimustine plus teniposide in recurrent glioblastoma. Journal of Clinical Oncology. 26(15_suppl). 13018–13018. 2 indexed citations

15.

Stuplich, Moritz, Andreas F. Hottinger, Christoforos Stoupis, & Mathias Sturzenegger. (2005). Combined femoral and obturator neuropathy caused by synovial cyst of the hip. Muscle & Nerve. 32(4). 552–554. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact